TL;DR
This study quantifies the significant economic burden of malposition and migration of umbilical venous catheters (UVCs) and peripherally inserted central catheters (PICCs) in neonates. By developing a mixed-methods cost model, the research highlights that addressing these issues could lead to substantial cost savings and improved patient outcomes in neonatal intensive care units.
What Problem Does This Paper Address?
Providing reliable vascular access is critical for neonates requiring intensive care. However, placing these essential lines, specifically UVCs and PICCs, is fraught with challenges. Malposition (incorrect initial placement) and migration (tip movement after insertion) are common complications that can lead to serious adverse events, prolonged hospital stays, and increased healthcare costs. While the clinical impact of these complications is recognized, the precise economic burden they impose on the healthcare system, particularly from a payer's perspective, has been poorly quantified. This paper aims to fill that gap by developing a detailed cost analysis to understand and attribute the financial impact of UVC and PICC malposition and migration in neonates.
Methods
The researchers employed a four-step, mixed-methods approach to develop and analyze an economic model for neonatal UVC and PICC insertion from a payer's perspective in the US.
- Initial Model Development: A decision-analytic model was constructed using TreeAge Pro Healthcare software. This model maps out potential pathways associated with catheter insertion, including complications, and attributes costs to each. Initial parameters were derived from a literature search.
- Initial Face Validity (Electronic Survey): The model structure and input parameters were presented to a group of North American clinical experts in vascular access. They provided feedback via an electronic survey to assess the model's accuracy and identify any missing elements or inaccuracies.
- Confirmatory Face Validity (Focus Group & Follow-up Survey): A face-to-face meeting with the same clinical experts was conducted to refine the model structure and parameter estimates based on their collective clinical experience. This was followed by a post-focus group survey to finalize adjustments.
- Analysis: The finalized model was analyzed to determine expected costs and complication rates. Deterministic sensitivity analyses were performed to assess the impact of varying key input parameters on the overall cost.
Datasets
Not discussed in the paper. The study primarily relies on existing literature and expert opinion for its data inputs.
Key Insights and Ideas
- Significant Economic Burden: Malposition and migration of UVCs and PICCs are not just clinical issues; they represent a substantial financial drain on healthcare systems.
- Migration is a Major Cost Driver for PICCs: For PICCs, migration accounts for a disproportionately large share of the total cost, highlighting the importance of strategies to prevent tip movement after insertion.
- Malposition is More Costly Initially for UVCs: In contrast, for UVCs, initial malposition contributes more to the cost than migration, suggesting that improving initial placement accuracy is crucial.
- Dwell Time is Key: Catheter dwell time emerged as a critical factor influencing costs, directly impacting monitoring costs and the probability of more expensive migration-related complications.
- Expert Consensus is Vital: The mixed-methods approach, combining literature review with extensive expert input, was crucial for building a robust and clinically relevant model.
Key Results
- Base Case Costs:
- Umbilical Venous Catheter (UVC): $390.24 per patient.
- Peripherally Inserted Central Catheter (PICC): $1517.83 per patient.
- Attributable Costs:
- UVC: Malposition accounted for $82.73 and migration for $46.36 per patient.
- PICC: Malposition accounted for $75.58 and migration for $755.14 per patient.
- Impact of Eliminating Complications:
- Switching to a "zero malposition" scenario for UVCs reduced costs by approximately 21% ($307.54).
- Eliminating migration for UVCs reduced costs by approximately 12% ($343.91).
- For PICCs, eliminating malposition reduced costs by about 5% ($1442.25), while eliminating migration led to a substantial reduction of nearly 50% ($762.69).
- Top Cost Drivers: Catheter dwell time, probability of catheter migration, and daily monitoring costs were identified as the top three drivers of expected cost for both UVCs and PICCs.
Limitations and Future Work
- Reliance on Expert Opinion: While expert opinion was crucial for model validation, it introduces a degree of subjectivity. The study acknowledges the variability in clinician opinions and incorporated it into sensitivity analyses.
- Foreign Costing Data: In instances where US-specific cost data was unavailable, foreign costing data was used and adjusted. While affirmed by clinicians, this remains an imperfect solution.
- US-Centric: The study's findings are specific to the US healthcare context, limiting direct generalizability to international settings without recalibration.
- Future Research: The authors suggest validating these findings with real-world hospital billing data. They also propose that innovations like intracavitary electrocardiography tip location devices could be promising for reducing insertion and post-insertion complications, warranting further cost-effectiveness analysis. Prioritizing the prevention of migration and malposition through evidence-based solutions is emphasized as a key objective for neonatal intensive care units.
Summary updated